Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
R Tang, J Xu, B Zhang, J Liu, C Liang, J Hua… - Journal of hematology & …, 2020 - Springer
In recent years, cancer immunotherapy based on immune checkpoint inhibitors (ICIs) has
achieved considerable success in the clinic. However, ICIs are significantly limited by the …
achieved considerable success in the clinic. However, ICIs are significantly limited by the …
Protective effects of omega-3 fatty acids in cancer-related complications
RDS Freitas, MM Campos - Nutrients, 2019 - mdpi.com
Omega-3 polyunsaturated fatty acids (PUFAs) are considered immunonutrients and are
commonly used in the nutritional therapy of cancer patients due to their ample biological …
commonly used in the nutritional therapy of cancer patients due to their ample biological …
The influence of nutritional factors on immunological outcomes
E Tourkochristou, C Triantos, A Mouzaki - Frontiers in immunology, 2021 - frontiersin.org
Through food intake, humans obtain a variety of nutrients that are essential for growth,
cellular function, tissue development, energy, and immune defense. A special interaction …
cellular function, tissue development, energy, and immune defense. A special interaction …
[HTML][HTML] The effect of long chain omega-3 polyunsaturated fatty acids on muscle mass and function in sarcopenia: a scoping systematic review and meta-analysis
Summary Background & Aims Sarcopenia is characterized by the progressive loss of
skeletal muscle mass and function, which reduces mobility and quality of life. Risk factors for …
skeletal muscle mass and function, which reduces mobility and quality of life. Risk factors for …
Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies
Mineral oil is often used as a clinical trial placebo. Pharmaceutical-grade mineral oil consists
of a mixture of saturated hydrocarbons, with a purity and chemical structure that differs …
of a mixture of saturated hydrocarbons, with a purity and chemical structure that differs …
Nutritional status and follicular-derived thyroid cancer: An update
L Barrea, M Gallo, RM Ruggeri… - Critical reviews in …, 2021 - Taylor & Francis
The incidence of differentiated thyroid cancer has been increasing in the last decades all
over the world. Such a steady growth cannot be entirely attributable to more intensive thyroid …
over the world. Such a steady growth cannot be entirely attributable to more intensive thyroid …
Oncoinformatic screening of the gene clusters involved in the HER2-positive breast cancer formation along with the in silico pharmacodynamic profiling of selective …
The HER2-positive patients occupy~ 30% of the total breast cancer patients globally where
no prevalent drugs are available to mitigate the frequent metastasis clinically except …
no prevalent drugs are available to mitigate the frequent metastasis clinically except …
Functional foods modulating inflammation and metabolism in chronic diseases: a systematic review
J Luvián-Morales, FO Varela-Castillo… - Critical Reviews in …, 2022 - Taylor & Francis
Chronic diseases are responsible for approximately 71% global deaths. These are
characterized by chronic low-grade inflammation and metabolic alterations.“Functional …
characterized by chronic low-grade inflammation and metabolic alterations.“Functional …
Relevance of dietary supplement use in gastrointestinal-Cancer-associated Cachexia
SL Yoon, O Grundmann - Nutrients, 2023 - mdpi.com
Cancer cachexia is a multi-organ syndrome with unintentional weight loss, sarcopenia, and
systemic inflammation. Gastrointestinal (GI) cancer patients are more susceptible to …
systemic inflammation. Gastrointestinal (GI) cancer patients are more susceptible to …
[HTML][HTML] The emerging role of PPAR-alpha in breast cancer
Z Qian, L Chen, J Liu, Y Jiang, Y Zhang - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Breast cancer has been confirmed to have lipid disorders in the tumour microenvironment.
Peroxisome proliferator-activated receptor alpha (PPARα) is a ligand-activated …
Peroxisome proliferator-activated receptor alpha (PPARα) is a ligand-activated …